Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract

K. T. Barnhart, A. Stolpen, E. S. Pretorius, Daniel Malamud

Research output: Contribution to journalArticle

Abstract

Topical, intravaginal microbicides and spermicides are greatly needed to prevent transmission of sexually transmitted disease and/or unwanted pregnancies. The development of such compounds is a high research priority. The presumed method of action of existing, or novel, microbicides/spermicides is to provide a chemical barrier to the vaginal epithelium preventing exposure to micro-organisms. Other intravaginal products are used to treat vaginal bacteria of fungal infections. Little is known, however, about the actual or optimal initial distribution and subsequent spread of medications placed in the vagina. We describe a sensitive new technique to quantify the spread of a gel placed in the vagina using magnetic resonance imaging (MRI). Five millilitres of an over-the-counter spermicide containing Nonoxynol-9 was mixed with Gadolinium. MRI was used to quantify spread of the mixture 10 min after insertion with a standard applicator. We demonstrated contiguous spread of gel throughout the vagina. The coverage of material was thicker in the upper vagina than in the lower vagina. We also demonstrated, for the first time, that spermicidal compounds may migrate from the vaginal canal into the endocervix within 10 min of insertion. This finding suggests that topical microbicides/spermicides may act both in the vaginal canal and in the upper female genital tract.

Original languageEnglish (US)
Pages (from-to)1151-1154
Number of pages4
JournalHuman Reproduction
Volume16
Issue number6
StatePublished - 2001

Fingerprint

Nonoxynol
Vagina
Local Anti-Infective Agents
Gels
Magnetic Resonance Imaging
Unwanted Pregnancies
Mycoses
Gadolinium
Sexually Transmitted Diseases
Anti-Infective Agents
Epithelium
Bacteria
Research

Keywords

  • Microbicide
  • MRI
  • Nonoxynol-9
  • Spermicide
  • Vagina

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract. / Barnhart, K. T.; Stolpen, A.; Pretorius, E. S.; Malamud, Daniel.

In: Human Reproduction, Vol. 16, No. 6, 2001, p. 1151-1154.

Research output: Contribution to journalArticle

@article{32dc3ffec594460aa30edea51c795ca9,
title = "Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract",
abstract = "Topical, intravaginal microbicides and spermicides are greatly needed to prevent transmission of sexually transmitted disease and/or unwanted pregnancies. The development of such compounds is a high research priority. The presumed method of action of existing, or novel, microbicides/spermicides is to provide a chemical barrier to the vaginal epithelium preventing exposure to micro-organisms. Other intravaginal products are used to treat vaginal bacteria of fungal infections. Little is known, however, about the actual or optimal initial distribution and subsequent spread of medications placed in the vagina. We describe a sensitive new technique to quantify the spread of a gel placed in the vagina using magnetic resonance imaging (MRI). Five millilitres of an over-the-counter spermicide containing Nonoxynol-9 was mixed with Gadolinium. MRI was used to quantify spread of the mixture 10 min after insertion with a standard applicator. We demonstrated contiguous spread of gel throughout the vagina. The coverage of material was thicker in the upper vagina than in the lower vagina. We also demonstrated, for the first time, that spermicidal compounds may migrate from the vaginal canal into the endocervix within 10 min of insertion. This finding suggests that topical microbicides/spermicides may act both in the vaginal canal and in the upper female genital tract.",
keywords = "Microbicide, MRI, Nonoxynol-9, Spermicide, Vagina",
author = "Barnhart, {K. T.} and A. Stolpen and Pretorius, {E. S.} and Daniel Malamud",
year = "2001",
language = "English (US)",
volume = "16",
pages = "1151--1154",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract

AU - Barnhart, K. T.

AU - Stolpen, A.

AU - Pretorius, E. S.

AU - Malamud, Daniel

PY - 2001

Y1 - 2001

N2 - Topical, intravaginal microbicides and spermicides are greatly needed to prevent transmission of sexually transmitted disease and/or unwanted pregnancies. The development of such compounds is a high research priority. The presumed method of action of existing, or novel, microbicides/spermicides is to provide a chemical barrier to the vaginal epithelium preventing exposure to micro-organisms. Other intravaginal products are used to treat vaginal bacteria of fungal infections. Little is known, however, about the actual or optimal initial distribution and subsequent spread of medications placed in the vagina. We describe a sensitive new technique to quantify the spread of a gel placed in the vagina using magnetic resonance imaging (MRI). Five millilitres of an over-the-counter spermicide containing Nonoxynol-9 was mixed with Gadolinium. MRI was used to quantify spread of the mixture 10 min after insertion with a standard applicator. We demonstrated contiguous spread of gel throughout the vagina. The coverage of material was thicker in the upper vagina than in the lower vagina. We also demonstrated, for the first time, that spermicidal compounds may migrate from the vaginal canal into the endocervix within 10 min of insertion. This finding suggests that topical microbicides/spermicides may act both in the vaginal canal and in the upper female genital tract.

AB - Topical, intravaginal microbicides and spermicides are greatly needed to prevent transmission of sexually transmitted disease and/or unwanted pregnancies. The development of such compounds is a high research priority. The presumed method of action of existing, or novel, microbicides/spermicides is to provide a chemical barrier to the vaginal epithelium preventing exposure to micro-organisms. Other intravaginal products are used to treat vaginal bacteria of fungal infections. Little is known, however, about the actual or optimal initial distribution and subsequent spread of medications placed in the vagina. We describe a sensitive new technique to quantify the spread of a gel placed in the vagina using magnetic resonance imaging (MRI). Five millilitres of an over-the-counter spermicide containing Nonoxynol-9 was mixed with Gadolinium. MRI was used to quantify spread of the mixture 10 min after insertion with a standard applicator. We demonstrated contiguous spread of gel throughout the vagina. The coverage of material was thicker in the upper vagina than in the lower vagina. We also demonstrated, for the first time, that spermicidal compounds may migrate from the vaginal canal into the endocervix within 10 min of insertion. This finding suggests that topical microbicides/spermicides may act both in the vaginal canal and in the upper female genital tract.

KW - Microbicide

KW - MRI

KW - Nonoxynol-9

KW - Spermicide

KW - Vagina

UR - http://www.scopus.com/inward/record.url?scp=0034974658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034974658&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 1151

EP - 1154

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 6

ER -